selected publications
- Pediatric-Type Follicular Lymphoma of the Conjunctiva in Two Adolescents. 2024 GET IT
- ARID1A orchestrates SWI/SNF-mediated sequential binding of transcription factors with ARID1A loss driving pre-memory B cell fate and lymphomagenesis. 2024 GET IT
- Loss of CREBBP and KMT2D cooperate to accelerate lymphomagenesis and shape the lymphoma immune microenvironment. Nature communications. 2024 Academic Article GET IT
- ARID1A orchestrates SWI/SNF-mediated sequential binding of transcription factors with ARID1A loss driving pre-memory B cell fate and lymphomagenesis. Cancer cell. 2024 Academic Article GET IT
- SMARCA4 is a haploinsufficient B cell lymphoma tumor suppressor that fine-tunes centrocyte cell fate decisions. Cancer cell. 2024 Academic Article GET IT
- 5th Edition of the World Health Classification of Tumors of the Hematopoietic and Lymphoid Tissues: B-cell Neoplasms. Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc. 2024 Review GET IT
- Immune deficiency/dysregulation -associated lymphoproliferative disorders. Revised classification and management. Blood reviews. 2024 Review GET IT
- Improved Utilization of Serial Testing Without Increased Admissions after Implementation of High-Sensitivity Troponin I: a Controlled Retrospective Cohort Study. Journal of general internal medicine. 2023 Academic Article GET IT
- The pathobiology of select adolescent young adult lymphomas. EJHaem. 2023 Review GET IT
- Lymphomas included in the AIDS case definition: an update 30 years later. The lancet. HIV. 2023 Letter GET IT
-
Epigenetic memory of coronavirus infection in innate immune cells and their progenitors.
Cell.
2023
Academic Article
GET IT
Times cited: 2 - Brentuximab vedotin with AVD for stage II-IV HIV-related Hodgkin lymphoma (AMC 085): phase 2 results from an open-label, single arm, multicentre phase 1/2 trial. The Lancet. Haematology. 2023 Academic Article GET IT
- Post-transplant lymphoproliferative disorders (PTLD) in adolescents and young adults: A category in need of definition. Seminars in diagnostic pathology. 2023 Review GET IT
- Primary Effusion Lymphoma in an HIV-Negative Patient with Chronic Myeloid Leukemia Treated with Dasatinib. 2023 GET IT
- EBV-positive PCNSL in older patients: incidence, characteristics, tumor pathology, and outcomes across a large multicenter cohort. Leukemia & lymphoma. 2023 Academic Article GET IT
- Primary Mediastinal B-Cell Lymphoma in Children and Young Adults. Journal of the National Comprehensive Cancer Network : JNCCN. 2023 Review GET IT
- BTG1 mutation yields supercompetitive B cells primed for malignant transformation. Science (New York, N.Y.). 2023 Academic Article GET IT
- Distinct Laboratory Test Result Profiles Between SARS-CoV-2 and Seasonable Influenza Infected Patients. Annals of clinical and laboratory science. 2022 Academic Article GET IT
- GENETIC SUBGROUPS INFORM ON PATHOBIOLOGY IN ADULT AND PEDIATRIC BURKITT LYMPHOMA. Blood. 2022 Academic Article GET IT
- The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms. Leukemia. 2022 Review GET IT
-
C5b-9 and MASP2 deposition in skin and bone marrow microvasculature characterize hematopoietic stem cell transplant-associated thrombotic microangiopathy.
Bone marrow transplantation.
2022
Letter
GET IT
Times cited: 1 - SETD2 haploinsufficiency enhances germinal center-associated AICDA somatic hypermutation to drive B cell lymphomagenesis. Cancer discovery. 2022 Academic Article GET IT
- Metagenomic analysis to identify novel infectious agents in systemic anaplastic large cell lymphoma. Infectious agents and cancer. 2021 Academic Article GET IT
-
Rapid, robust, and sustainable antibody responses to mRNA COVID-19 vaccine in convalescent COVID-19 individuals.
JCI insight.
2021
Academic Article
GET IT
Times cited: 17 - Genetic profiling and biomarkers in peripheral T-cell lymphomas: current role in the diagnostic work-up. Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc. 2021 Review GET IT
-
TOP-Plus Is a Versatile Biosensor Platform for Monitoring SARS-CoV-2 Antibody Durability.
Clinical chemistry.
2021
Academic Article
GET IT
Times cited: 11 - Comparison of Multiple Clinical Testing Modalities for Assessment of NPM1-Mutant AML. Frontiers in oncology. 2021 Academic Article GET IT
- Mast cell sarcoma transdifferentiated from clonally-related T-lymphoblastic leukemia upon acquisition of TP53 mutation and genetic complexity. Leukemia & lymphoma. 2021 Article GET IT
-
ROR1 targeting with the antibody-drug conjugate VLS-101 is effective in Richter syndrome patient-derived xenograft mouse models.
Blood.
2021
Academic Article
GET IT
Times cited: 61 -
Synergistic efficacy of the dual PI3K-δ/γ inhibitor duvelisib with the Bcl-2 inhibitor venetoclax in Richter syndrome PDX models.
Blood.
2021
Academic Article
GET IT
Times cited: 1 -
Machine Learning Highlights Downtrending of COVID-19 Patients with a Distinct Laboratory Profile.
Health data science.
2021
Academic Article
GET IT
Times cited: 5 -
Postconvalescent SARS-CoV-2 IgG and Neutralizing Antibodies are Elevated in Individuals with Poor Metabolic Health.
The Journal of clinical endocrinology and metabolism.
2021
Academic Article
GET IT
Times cited: 23 -
Association of Age With SARS-CoV-2 Antibody Response.
JAMA network open.
2021
Academic Article
GET IT
Times cited: 139 -
Biomarkers for Risk Stratification in Patients With Previously Untreated Follicular Lymphoma Receiving Anti-CD20-based Biological Therapy.
The American journal of surgical pathology.
2021
Academic Article
GET IT
Times cited: 14 -
Response-adapted therapy with infusional EPOCH chemotherapy plus rituximab in HIV-associated, B-cell non-Hodgkin's lymphoma.
Haematologica.
2021
Academic Article
GET IT
Times cited: 9 -
Testing-on-a-probe biosensors reveal association of early SARS-CoV-2 total antibodies and surrogate neutralizing antibodies with mortality in COVID-19 patients.
Biosensors & bioelectronics.
2021
Academic Article
GET IT
Times cited: 18 -
ACCELERATE: A Patient-Powered Natural History Study Design Enabling Clinical and Therapeutic Discoveries in a Rare Disorder.
Cell reports. Medicine.
2020
Academic Article
GET IT
Times cited: 21 -
International evidence-based consensus diagnostic and treatment guidelines for unicentric Castleman disease.
Blood advances.
2020
Academic Article
GET IT
Times cited: 115 - Targeted reduction of cholesterol uptake in cholesterol-addicted lymphoma cells blocks turnover of oxidized lipids to cause ferroptosis. The Journal of biological chemistry. 2020 Academic Article GET IT
-
Routine Laboratory Blood Tests Predict SARS-CoV-2 Infection Using Machine Learning.
Clinical chemistry.
2020
Academic Article
GET IT
Times cited: 82 -
COVID-19 Viral and Serology Testing in New York City Health Care Workers.
American journal of clinical pathology.
2020
Academic Article
GET IT
Times cited: 10 -
Insufficient evidence exists to use histopathologic subtype to guide treatment of idiopathic multicentric Castleman disease.
American journal of hematology.
2020
Academic Article
GET IT
Times cited: 5 -
Autopsy Findings in 32 Patients with COVID-19: A Single-Institution Experience.
Pathobiology : journal of immunopathology, molecular and cellular biology.
2020
Academic Article
GET IT
Times cited: 100 -
Impact of Myc in HIV-associated non-Hodgkin lymphomas treated with EPOCH and outcomes with vorinostat (AMC-075 trial).
Blood.
2020
Academic Article
GET IT
Times cited: 42 -
TBL1XR1 Mutations Drive Extranodal Lymphoma by Inducing a Pro-tumorigenic Memory Fate.
Cell.
2020
Academic Article
GET IT
Times cited: 71 -
Spleen: Development, anatomy and reactive lymphoid proliferations.
Seminars in diagnostic pathology.
2020
Information Resource
GET IT
Times cited: 3 -
SARS-CoV-2 antibody characterization in emergency department, hospitalized and convalescent patients by two semi-quantitative immunoassays.
Clinica chimica acta; international journal of clinical chemistry.
2020
Academic Article
GET IT
Times cited: 31 -
Virome capture sequencing does not identify active viral infection in unicentric and idiopathic multicentric Castleman disease.
PloS one.
2019
Academic Article
GET IT
Times cited: 26 -
Limited Tissue Samples: Hematopoietic Lesions - Three Case Examples of Judicious Use of Limited Material.
Acta cytologica.
2019
Information Resource
GET IT
Times cited: 1 -
Dose-Adjusted EPOCH-R Compared With R-CHOP as Frontline Therapy for Diffuse Large B-Cell Lymphoma: Clinical Outcomes of the Phase III Intergroup Trial Alliance/CALGB 50303.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
2019
Academic Article
GET IT
Times cited: 292 -
International, evidence-based consensus treatment guidelines for idiopathic multicentric Castleman disease.
Blood.
2018
Academic Article
GET IT
Times cited: 261 -
Novel Richter Syndrome Xenograft Models to Study Genetic Architecture, Biology, and Therapy Responses.
Cancer research.
2018
Academic Article
GET IT
Times cited: 13 -
KSHV induces immunoglobulin rearrangements in mature B lymphocytes.
PLoS pathogens.
2018
Academic Article
GET IT
Times cited: 28 -
Assessment of the Utility of Cytology and Flow Cytometry of Cerebrospinal Fluid Samples in Clinical Practice.
Acta cytologica.
2018
Academic Article
GET IT
Times cited: 3 -
Genetic and Functional Drivers of Diffuse Large BÂ Cell Lymphoma.
Cell.
2017
Academic Article
GET IT
Times cited: 782 -
Inhibition of Hsp90 Suppresses PI3K/AKT/mTOR Signaling and Has Antitumor Activity in Burkitt Lymphoma.
Molecular cancer therapeutics.
2017
Academic Article
GET IT
Times cited: 60 -
The eIF4E inhibitor ribavirin as a potential antilymphoma therapeutic: early clinical data.
Leukemia & lymphoma.
2017
Letter
GET IT
Times cited: 4 -
Resolution of a steroid-resistant, hypereosinophilic immune diathesis with mepolizumab and concomitant amelioration of a mixed thrombotic microangiopathy.
2017
GET IT
Times cited: 3 -
Enteropathy-associated T cell lymphoma subtypes are characterized by loss of function of SETD2.
The Journal of experimental medicine.
2017
Academic Article
GET IT
Times cited: 147 -
The Genetic Basis of Hepatosplenic T-cell Lymphoma.
Cancer discovery.
2017
Academic Article
GET IT
Times cited: 164 -
International, evidence-based consensus diagnostic criteria for HHV-8-negative/idiopathic multicentric Castleman disease.
Blood.
2017
Academic Article
GET IT
Times cited: 396 -
Plasmablastic lymphoma is treatable in the HAART era. A 10 year retrospective by the AIDS Malignancy Consortium.
Leukemia & lymphoma.
2015
Article
GET IT
Times cited: 25 -
Hepatosplenic T-Cell Lymphoma Mimicking Acute Myeloid Leukemia.
2015
GET IT
Times cited: 5 - Transfusion medicine illustrated. Hemoglobin C after a red blood cell transfusion for sickle cell disease. 2015 GET IT
-
The tumor virus landscape of AIDS-related lymphomas.
Blood.
2015
Academic Article
GET IT
Times cited: 63 -
Flow sorting and exome sequencing reveal the oncogenome of primary Hodgkin and Reed-Sternberg cells.
Blood.
2014
Academic Article
GET IT
Times cited: 182 -
Pancreatitis in patients treated with brentuximab vedotin: a previously unrecognized serious adverse event.
Blood.
2014
Article
GET IT
Times cited: 52 -
Genetics of follicular lymphoma transformation.
Cell reports.
2014
Academic Article
GET IT
Times cited: 456 -
Mechanism-based epigenetic chemosensitization therapy of diffuse large B-cell lymphoma.
Cancer discovery.
2013
Academic Article
GET IT
Times cited: 163 -
Nuclear protein dysregulation in lymphoplasmacytic lymphoma/waldenstrom macroglobulinemia.
American journal of clinical pathology.
2013
Academic Article
GET IT
Times cited: 15 -
Genetic heterogeneity of diffuse large B-cell lymphoma.
Proceedings of the National Academy of Sciences of the United States of America.
2013
Academic Article
GET IT
Times cited: 459 -
Molecular and immunohistochemical detection of Kaposi sarcoma herpesvirus/human herpesvirus-8.
Methods in molecular biology (Clifton, N.J.).
2013
Academic Article
GET IT
Times cited: 3 -
The genetic landscape of mutations in Burkitt lymphoma.
Nature genetics.
2012
Academic Article
GET IT
Times cited: 481 - 13th International Conference on Malignancies in AIDS and Other Acquired Immunodeficiencies (ICMAOI) Bethesda, MD, USA. 7-8 November 2011. Abstracts. Infectious agents and cancer. 2012 Academic Article GET IT
-
A Cancer and Leukemia Group B multi-center study of DA-EPOCH-rituximab in untreated diffuse large B-cell lymphoma with analysis of outcome by molecular subtype.
Haematologica.
2011
Academic Article
GET IT
Times cited: 154 -
Clinical, morphologic, immunophenotypic, and molecular cytogenetic assessment of CD4-/CD8-γδ T-cell large granular lymphocytic leukemia.
American journal of clinical pathology.
2011
Academic Article
GET IT
Times cited: 30 -
Analysis of the coding genome of diffuse large B-cell lymphoma.
Nature genetics.
2011
Academic Article
GET IT
Times cited: 835 -
A20 (TNFAIP3) genetic alterations in EBV-associated AIDS-related lymphoma.
Blood.
2011
Academic Article
GET IT
Times cited: 29 -
Inactivating mutations of acetyltransferase genes in B-cell lymphoma.
Nature.
2011
Academic Article
GET IT
Times cited: 771 -
Normal bone marrow signal-transduction profiles: a requisite for enhanced detection of signaling dysregulations in AML.
Blood.
2011
Academic Article
GET IT
Times cited: 25 -
Bortezomib plus CHOP-rituximab for previously untreated diffuse large B-cell lymphoma and mantle cell lymphoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
2010
Academic Article
GET IT
Times cited: 257 -
BLIMP1 is a tumor suppressor gene frequently disrupted in activated B cell-like diffuse large B cell lymphoma.
Cancer cell.
2010
Academic Article
GET IT
Times cited: 250 -
Post-transplantation lymphoproliferative disorders: diagnosis, prognosis, and current approaches to therapy.
Current oncology reports.
2010
Information Resource
GET IT
Times cited: 104 -
Primary effusion lymphoma: genomic profiling revealed amplification of SELPLG and CORO1C encoding for proteins important for cell migration.
The Journal of pathology.
2010
Academic Article
GET IT
Times cited: 42 -
Deep sequencing of the small RNA transcriptome of normal and malignant human B cells identifies hundreds of novel microRNAs.
Blood.
2010
Academic Article
GET IT
Times cited: 184 -
Epigenetic down-regulation of the tumor suppressor gene PRDM1/Blimp-1 in diffuse large B cell lymphomas: a potential role of the microRNA let-7.
The American journal of pathology.
2010
Academic Article
GET IT
Times cited: 55 -
Response to second-line therapy defines the potential for cure in patients with recurrent diffuse large B-cell lymphoma: implications for the development of novel therapeutic strategies.
Clinical lymphoma, myeloma & leukemia.
2010
Academic Article
GET IT
Times cited: 39 -
NK/T cell non-Hodgkin lymphoma in a HIV-positive patient.
Journal of hematopathology.
2010
Academic Article
GET IT
Times cited: 4 -
Expression of cancer testis antigen CT45 in classical Hodgkin lymphoma and other B-cell lymphomas.
Proceedings of the National Academy of Sciences of the United States of America.
2010
Academic Article
GET IT
Times cited: 37 -
Multicenter analysis of 80 solid organ transplantation recipients with post-transplantation lymphoproliferative disease: outcomes and prognostic factors in the modern era.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
2010
Academic Article
GET IT
Times cited: 271 -
Rituximab plus concurrent infusional EPOCH chemotherapy is highly effective in HIV-associated B-cell non-Hodgkin lymphoma.
Blood.
2009
Academic Article
GET IT
Times cited: 218 -
The mechanisms underlying MMR deficiency in immunodeficiency-related non-Hodgkin lymphomas are different from those in other sporadic microsatellite instable neoplasms.
International journal of cancer.
2009
Academic Article
GET IT
Times cited: 14 -
Targeted disruption of the S1P2 sphingosine 1-phosphate receptor gene leads to diffuse large B-cell lymphoma formation.
Cancer research.
2009
Academic Article
GET IT
Times cited: 111 -
Immunophenotypic analysis of AIDS-related diffuse large B-cell lymphoma and clinical implications in patients from AIDS Malignancies Consortium clinical trials 010 and 034.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
2009
Academic Article
GET IT
Times cited: 84 -
HIV-1 evades virus-specific IgG2 and IgA responses by targeting systemic and intestinal B cells via long-range intercellular conduits.
Nature immunology.
2009
Academic Article
GET IT
Times cited: 247 -
Diffuse blastoid B-cell lymphoma: a histologically aggressive variant of t(14;18)-negative follicular lymphoma.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.
2009
Academic Article
GET IT
Times cited: 12 -
BCL6 suppression of BCL2 via Miz1 and its disruption in diffuse large B cell lymphoma.
Proceedings of the National Academy of Sciences of the United States of America.
2009
Academic Article
GET IT
Times cited: 168 -
Priming of protective T cell responses against virus-induced tumors in mice with human immune system components.
The Journal of experimental medicine.
2009
Academic Article
GET IT
Times cited: 248 -
Mutations of multiple genes cause deregulation of NF-kappaB in diffuse large B-cell lymphoma.
Nature.
2009
Academic Article
GET IT
Times cited: 912 -
The stromal composition of mast cell aggregates in systemic mastocytosis.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.
2009
Academic Article
GET IT
Times cited: 10 -
Lymphoma diagnosis and plasma Epstein-Barr virus load during vicriviroc therapy: results of the AIDS Clinical Trials Group A5211.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
2009
Academic Article
GET IT
Times cited: 17 -
Role of defective Oct-2 and OCA-B expression in immunoglobulin production and Kaposi's sarcoma-associated herpesvirus lytic reactivation in primary effusion lymphoma.
Journal of virology.
2009
Academic Article
GET IT
Times cited: 12 -
Outcome of deferred initial therapy in mantle-cell lymphoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
2009
Academic Article
GET IT
Times cited: 254 -
Patients with Epstein Barr virus-positive lymphomas have decreased CD4(+) T-cell responses to the viral nuclear antigen 1.
International journal of cancer.
2008
Academic Article
GET IT
Times cited: 30 -
Expression of the follicular lymphoma variant translocation 1 gene in diffuse large B-cell lymphoma correlates with subtype and clinical outcome.
American journal of clinical pathology.
2008
Academic Article
GET IT
Times cited: 6 -
Immunophenotypic analysis of the Kaposi sarcoma herpesvirus (KSHV; HHV-8)-infected B cells in HIV+ multicentric Castleman disease (MCD).
Histopathology.
2008
Academic Article
GET IT
Times cited: 56 -
A peptomimetic inhibitor of BCL6 with potent antilymphoma effects in vitro and in vivo.
Blood.
2008
Academic Article
GET IT
Times cited: 153 -
Tyrosine kinase inhibition in diffuse large B-cell lymphoma: molecular basis for antitumor activity and drug resistance of dasatinib.
Leukemia.
2008
Academic Article
GET IT
Times cited: 52 -
MicroRNA-mediated down-regulation of PRDM1/Blimp-1 in Hodgkin/Reed-Sternberg cells: a potential pathogenetic lesion in Hodgkin lymphomas.
The American journal of pathology.
2008
Academic Article
GET IT
Times cited: 143 -
CD133 expression is not restricted to stem cells, and both CD133+ and CD133- metastatic colon cancer cells initiate tumors.
The Journal of clinical investigation.
2008
Academic Article
GET IT
Times cited: 816 -
Decreased differentiation of erythroid cells exacerbates ineffective erythropoiesis in beta-thalassemia.
Blood.
2008
Academic Article
GET IT
Times cited: 142 -
FDG-PET in prediction of splenectomy findings in patients with known or suspected lymphoma.
Leukemia & lymphoma.
2008
Academic Article
GET IT
Times cited: 15 -
Intensive treatment strategies may not provide superior outcomes in mantle cell lymphoma: overall survival exceeding 7 years with standard therapies.
Annals of oncology : official journal of the European Society for Medical Oncology.
2008
Academic Article
GET IT
Times cited: 63 -
Improving outcomes for patients with Burkitt lymphoma and HIV.
AIDS patient care and STDs.
2008
Review
GET IT
Times cited: 18 -
Phase 1/2 trial of BMS-275291 in patients with human immunodeficiency virus-related Kaposi sarcoma: a multicenter trial of the AIDS Malignancy Consortium.
Cancer.
2008
Academic Article
GET IT
Times cited: 11 -
KSHV LANA inhibits TGF-beta signaling through epigenetic silencing of the TGF-beta type II receptor.
Blood.
2008
Academic Article
GET IT
Times cited: 106 -
Intestinal bacteria trigger T cell-independent immunoglobulin A(2) class switching by inducing epithelial-cell secretion of the cytokine APRIL.
Immunity.
2007
Academic Article
GET IT
Times cited: 533 -
Lack of A563G (I188V) missense mutation in RIZ/ PRDM2 in human diffuse large B-cell lymphomas.
Genes, chromosomes & cancer.
2007
Article
GET IT
Times cited: 6 -
Ineffective erythropoiesis in beta-thalassemia is characterized by increased iron absorption mediated by down-regulation of hepcidin and up-regulation of ferroportin.
Blood.
2007
Academic Article
GET IT
Times cited: 271 -
Activation of peroxisome proliferator-activated receptor gamma contributes to the survival of T lymphoma cells by affecting cellular metabolism.
The American journal of pathology.
2007
Academic Article
GET IT
Times cited: 28 -
Dose-attenuated radioimmunotherapy with tositumomab and iodine 131 tositumomab in patients with recurrent non-Hodgkin's lymphoma (NHL) and extensive bone marrow involvement.
Leukemia & lymphoma.
2007
Academic Article
GET IT
Times cited: 11 -
Epithelial cells trigger frontline immunoglobulin class switching through a pathway regulated by the inhibitor SLPI.
Nature immunology.
2007
Academic Article
GET IT
Times cited: 234 -
Magnitude of stromal hemangiogenesis correlates with histologic subtype of non-Hodgkin's lymphoma.
Clinical cancer research : an official journal of the American Association for Cancer Research.
2006
Academic Article
GET IT
Times cited: 66 -
Hodgkin lymphoma cells express TACI and BCMA receptors and generate survival and proliferation signals in response to BAFF and APRIL.
Blood.
2006
Academic Article
GET IT
Times cited: 176 -
HIV-1 envelope triggers polyclonal Ig class switch recombination through a CD40-independent mechanism involving BAFF and C-type lectin receptors.
Journal of immunology (Baltimore, Md. : 1950).
2006
Academic Article
GET IT
Times cited: 173 -
Human immunodeficiency virus 1 Nef suppresses CD40-dependent immunoglobulin class switching in bystander B cells.
Nature immunology.
2006
Academic Article
GET IT
Times cited: 183 -
Mutational analysis of PRDM1 indicates a tumor-suppressor role in diffuse large B-cell lymphomas.
Blood.
2006
Academic Article
GET IT
Times cited: 187 -
Pathology of B-cell non-Hodgkin's lymphomas and multiple myeloma.
Cancer treatment and research.
2006
Information Resource
GET IT
Times cited: 1 -
Intracranial nasal natural killer/T-cell lymphoma: immunopathologically-confirmed case and review of literature.
Journal of neuro-oncology.
2005
Information Resource
GET IT
Times cited: 24 -
Abbreviated chemotherapy with fludarabine followed by tositumomab and iodine I 131 tositumomab for untreated follicular lymphoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
2005
Academic Article
GET IT
Times cited: 139 -
Combination antibody therapy with epratuzumab and rituximab in relapsed or refractory non-Hodgkin's lymphoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
2005
Academic Article
GET IT
Times cited: 157 -
Rituximab does not improve clinical outcome in a randomized phase 3 trial of CHOP with or without rituximab in patients with HIV-associated non-Hodgkin lymphoma: AIDS-Malignancies Consortium Trial 010.
Blood.
2005
Academic Article
GET IT
Times cited: 362 -
Accumulation of miR-155 and BIC RNA in human B cell lymphomas.
Proceedings of the National Academy of Sciences of the United States of America.
2005
Academic Article
GET IT
Times cited: 1234 -
Distinct subsets of primary effusion lymphoma can be identified based on their cellular gene expression profile and viral association.
Journal of virology.
2005
Academic Article
GET IT
Times cited: 115 -
KSHV-positive solid lymphomas represent an extra-cavitary variant of primary effusion lymphoma.
The American journal of surgical pathology.
2004
Academic Article
GET IT
Times cited: 236 -
Epratuzumab, a humanized anti-CD22 antibody, in aggressive non-Hodgkin's lymphoma: phase I/II clinical trial results.
Clinical cancer research : an official journal of the American Association for Cancer Research.
2004
Academic Article
GET IT
Times cited: 194 -
Lymphoma B cells evade apoptosis through the TNF family members BAFF/BLyS and APRIL.
Journal of immunology (Baltimore, Md. : 1950).
2004
Academic Article
GET IT
Times cited: 238 -
CD44 loss in gastric stromal tumors as a prognostic marker.
The American journal of surgical pathology.
2004
Academic Article
GET IT
Times cited: 40 -
Virus dynamics and immune responses during treatment in patients coinfected with hepatitis C and HIV.
Journal of acquired immune deficiency syndromes (1999).
2004
Academic Article
GET IT
Times cited: 26 -
ETO protein of t(8;21) AML is a corepressor for Bcl-6 B-cell lymphoma oncoprotein.
Blood.
2003
Academic Article
GET IT
Times cited: 60 - The emergence of Ph-, trisomy -8+ cells in patients with chronic myeloid leukemia treated with imatinib mesylate. Experimental hematology. 2003 Academic Article GET IT
-
Phase I/II trial of epratuzumab (humanized anti-CD22 antibody) in indolent non-Hodgkin's lymphoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
2003
Academic Article
GET IT
Times cited: 225 -
Anaplastic large cell lymphoma arising in a silicone breast implant capsule: a case report and review of the literature.
Archives of pathology & laboratory medicine.
2003
Information Resource
GET IT
Times cited: 84 -
Human immunodeficiency virus (HIV)-associated polymorphic lymphoproliferative disorders.
The American journal of surgical pathology.
2003
Academic Article
GET IT
Times cited: 47 -
Gene expression profile analysis of AIDS-related primary effusion lymphoma (PEL) suggests a plasmablastic derivation and identifies PEL-specific transcripts.
Blood.
2003
Academic Article
GET IT
Times cited: 209 -
Lymphoid malignancies: immunophenotypic analysis.
Advances in clinical chemistry.
2003
Information Resource
GET IT
Times cited: 2 -
A novel murine model of Cooley anemia and its rescue by lentiviral-mediated human beta-globin gene transfer.
Blood.
2002
Academic Article
GET IT
Times cited: 183 -
DNA polymerase mu gene expression in B-cell non-Hodgkin's lymphomas: an analysis utilizing in situ hybridization.
The American journal of pathology.
2002
Academic Article
GET IT
Times cited: 10 -
Germinal center B cells regulate their capability to present antigen by modulation of HLA-DO.
The Journal of experimental medicine.
2002
Academic Article
GET IT
Times cited: 81 -
Successful treatment of murine beta-thalassemia intermedia by transfer of the human beta-globin gene.
Blood.
2002
Academic Article
GET IT
Times cited: 145 -
Analysis of the human herpesvirus 8 (HHV-8) genome and HHV-8 vIL-6 expression in archival cases of castleman disease at low risk for HIV infection.
American journal of clinical pathology.
2002
Academic Article
GET IT
Times cited: 40 -
Impaired recruitment of bone-marrow-derived endothelial and hematopoietic precursor cells blocks tumor angiogenesis and growth.
Nature medicine.
2001
Academic Article
GET IT
Times cited: 1638 -
BCL-6 protein is expressed in precursor T-cell lymphoblastic lymphoma and in prenatal and postnatal thymus.
Blood.
2001
Academic Article
GET IT
Times cited: 37 -
Autocrine stimulation of VEGFR-2 activates human leukemic cell growth and migration.
The Journal of clinical investigation.
2000
Academic Article
GET IT
Times cited: 419 -
Telomerase activity in B-cell non-Hodgkin lymphoma.
Cancer.
2000
Academic Article
GET IT
Times cited: 29 -
Inhibition of intestinal tumors by curcumin is associated with changes in the intestinal immune cell profile.
The Journal of surgical research.
2000
Academic Article
GET IT
Times cited: 92 -
Proliferative response of mantle cell lymphoma cells stimulated by CD40 ligation and IL-4.
Leukemia.
2000
Academic Article
GET IT
Times cited: 38 -
Mediastinal large B-cell lymphoma vs classic Hodgkin lymphoma.
American journal of clinical pathology.
1999
Editorial Article
GET IT
Times cited: 10 - An Unusual Sonographic Manifestation of Lymphoma of the Breast. The breast journal. 1999 Academic Article GET IT
-
Enhanced endothelial cell apoptosis in splenic tissues of patients with thrombotic thrombocytopenic purpura.
Blood.
1999
Academic Article
GET IT
Times cited: 65 -
Administration of an unconjugated bile acid increases duodenal tumors in a murine model of familial adenomatous polyposis.
Carcinogenesis.
1999
Academic Article
GET IT
Times cited: 76 -
Incidence and outcome of primary Epstein-Barr virus infection and lymphoproliferative disease in pediatric heart transplant recipients.
The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
1998
Academic Article
GET IT
Times cited: 50 -
BCL-6 gene mutations in posttransplantation lymphoproliferative disorders predict response to therapy and clinical outcome.
Blood.
1998
Academic Article
GET IT
Times cited: 124 -
The morphologic and molecular genetic categories of posttransplantation lymphoproliferative disorders are clinically relevant.
Cancer.
1998
Academic Article
GET IT
Times cited: 108 -
The sulfide metabolite of sulindac prevents tumors and restores enterocyte apoptosis in a murine model of familial adenomatous polyposis.
Carcinogenesis.
1998
Academic Article
GET IT
Times cited: 129 -
Apc gene mutation is associated with a dominant-negative effect upon intestinal cell migration.
Cancer research.
1997
Academic Article
GET IT
Times cited: 126 -
Epstein-Barr virus latent membrane protein-1 oncogene deletion in post-transplantation lymphoproliferative disorders.
The American journal of pathology.
1997
Academic Article
GET IT
Times cited: 31 -
Kaposi's sarcoma-associated herpesvirus sequences in benign lymphoid proliferations not associated with human immunodeficiency virus.
Cancer.
1997
Academic Article
GET IT
Times cited: 72 -
Epstein-Barr virus latent gene expression in primary effusion lymphomas containing Kaposi's sarcoma-associated herpesvirus/human herpesvirus-8.
Blood.
1997
Academic Article
GET IT
Times cited: 173 -
CD4+ T-cell induction of Fas-mediated apoptosis in Burkitt's lymphoma B cells.
Blood.
1996
Academic Article
GET IT
Times cited: 71 -
Primary effusion lymphoma: a distinct clinicopathologic entity associated with the Kaposi's sarcoma-associated herpes virus.
Blood.
1996
Academic Article
GET IT
Times cited: 903 -
Cyclooxygenase-2 overexpression and tumor formation are blocked by sulindac in a murine model of familial adenomatous polyposis.
Cancer research.
1996
Academic Article
GET IT
Times cited: 535 -
Molecular characterization of primary mediastinal B cell lymphoma.
The American journal of pathology.
1996
Academic Article
GET IT
Times cited: 78 -
Post-transplantation lymphoproliferative disorders arising in solid organ transplant recipients are usually of recipient origin.
The American journal of pathology.
1995
Academic Article
GET IT
Times cited: 77 -
De novo CD5-positive and Richter's syndrome-associated diffuse large B cell lymphomas are genotypically distinct.
The American journal of pathology.
1995
Academic Article
GET IT
Times cited: 101 -
Correlative morphologic and molecular genetic analysis demonstrates three distinct categories of posttransplantation lymphoproliferative disorders.
Blood.
1995
Academic Article
GET IT
Times cited: 523 -
Alterations of the beta-adrenergic receptor system after thoracic and abdominal surgery.
Anesthesia and analgesia.
1994
Academic Article
GET IT
Times cited: 23 -
Paraffin-resistant antigens detectable by antibodies L26 and polyclonal CD3 predict the B- or T-cell lineage of 95% of diffuse aggressive non-Hodgkin's lymphomas.
American journal of clinical pathology.
1994
Academic Article
GET IT
Times cited: 25 -
Phenotypic and functional characterization of T-BAM (CD40 ligand)+ T-cell non-Hodgkin's lymphoma.
Blood.
1994
Academic Article
GET IT
Times cited: 13 -
Molecular characterization of CD30+ anaplastic large-cell lymphoma: high frequency of c-myc proto-oncogene activation.
Blood.
1994
Academic Article
GET IT
Times cited: 61 -
Transferrin receptor expression in testis cancer.
Journal of the National Cancer Institute.
1994
Article
GET IT
Times cited: 1 -
Post-thymic T cell lymphomas frequently overexpress p53 protein but infrequently exhibit p53 gene mutations.
The American journal of pathology.
1994
Academic Article
GET IT
Times cited: 70 -
CD30 (Ki-1) positive anaplastic large cell lymphomas in individuals infected with the human immunodeficiency virus.
Cancer.
1993
Academic Article
GET IT
Times cited: 124 -
Down-regulation and desensitization of the beta-adrenergic receptor system of human lymphocytes after cardiac surgery.
Anesthesia and analgesia.
1993
Academic Article
GET IT
Times cited: 28 -
High levels of p53 protein expression do not correlate with p53 gene mutations in anaplastic large cell lymphoma.
The American journal of pathology.
1993
Academic Article
GET IT
Times cited: 122 -
Management of lymphoproliferative disorders after cardiac transplantation.
The Annals of thoracic surgery.
1993
Academic Article
GET IT
Times cited: 52 -
Structural and functional analysis of oncogenes and tumor suppressor genes in adult T-cell leukemia/lymphoma shows frequent p53 mutations.
Blood.
1992
Academic Article
GET IT
Times cited: 113 -
Monoclonal antibody OPD4 detects neoplastic T cells but does not distinguish between CD4 and CD8 neoplastic T cells in paraffin tissue sections.
Human pathology.
1992
Academic Article
GET IT
Times cited: 9 -
The bcl-2 gene translocation is undetectable in Hodgkin's disease by Southern blot hybridization and polymerase chain reaction.
The American journal of pathology.
1992
Academic Article
GET IT
Times cited: 30 -
T-cell activation-associated antigen expression by neoplastic T-cells.
Hematologic pathology.
1992
Academic Article
GET IT
Times cited: 9 -
The kinetics and temporal expression of T-cell activation-associated antigens CD15 (LeuM1), CD30 (Ki-1), EMA, and CD11c (LeuM5) by benign activated T cells.
Hematologic pathology.
1992
Academic Article
GET IT
Times cited: 37 -
Detection and characterization of human T-cell lymphotropic virus type I (HTLV-I) associated T-cell neoplasms in an HTLV-I nonendemic region by polymerase chain reaction.
Blood.
1991
Academic Article
GET IT
Times cited: 25 -
Hairy cell leukemia-associated antigen LeuM5 (CD11c) is preferentially expressed by benign activated and neoplastic CD8 T cells.
The American journal of pathology.
1990
Academic Article
GET IT
Times cited: 12 -
Progressive lymph node histology and its prognostic value in patients with acquired immunodeficiency syndrome and AIDS-related complex.
Human pathology.
1989
Academic Article
GET IT
Times cited: 48 -
Lymph node biopsy in patients with human immunodeficiency virus infections.
Archives of surgery (Chicago, Ill. : 1960).
1988
Academic Article
GET IT
Times cited: 4